FDA Inspection 1153267 — Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
The FDA completed an inspection of Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy on September 9, 2021 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 9, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bristol, TN (United States)